Drug & supplement interaction

Cannabichromene (cbc) + Ranibizumab

Ranibizumab brand names: Lucentis, Susvimo.

No Known Interaction

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated June 2026 · Pair last verified Sep 20, 2026

The bottom line No known interaction

We found no known interaction between Cannabichromene (cbc) and Ranibizumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share

Facebook Post Reddit Email

On this page

Interaction report

Cannabichromene (cbc) and Ranibizumab

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Ranibizumab and Cannabichromene (cbc) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Cannabichromene (cbc) safety at a glance

Cannabichromene (c... overall Not established Human safety data are very limited, so its long-term safety is not established.

Pregnancy Avoid Not enough safety data; cannabinoids are best avoided during pregnancy.

Breastfeeding Avoid Cannabinoids can pass into breast milk, so avoid use while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Ranibizumab and Cannabichromene (cbc)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›

Keep it in perspective

Cannabichromene (cbc) Does Interact With Other Medications

Cannabichromene (cbc) has 248 moderate known drug interactions in our database — Ranibizumab isn’t one of them. If you take anything else, check it against the full list below.

Moderate 248 No known interaction 2,582 (incl. Ranibizumab)

Taking anything else?

Check Another of Your Medications Against Cannabichromene (cbc)

Covers the 2,830 medications we’ve checked against Cannabichromene (cbc). Pick one to open its full report.

What to actually watch for

What Ranibizumab’s Own FDA Label Lists

This is not an interaction — none of it involves Cannabichromene (cbc). These are the most notable effects listed in the ADVERSE REACTIONS section of Ranibizumab’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 5 of them are worth acting on rather than waiting out — marked below.

An irregular heartbeat Worth acting on
Kidney problems Worth acting on
Bleeding or bruising Worth acting on mentioned in 4.0% of FDA reports for Ranibizumab
Anemia Worth acting on
A higher chance of infection Worth acting on
Blurred vision mentioned in 21.1% of FDA reports for Ranibizumab
Eye irritation or redness
Dry eyes
Heartburn
Numbness or tingling

Showing the 10 most notable of 16 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Ranibizumab. Read the label on DailyMed › Where a percentage is shown, it is the share of 26,416 voluntary FDA FAERS reports for Ranibizumab that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Cannabichromene (cbc)’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Cannabichromene (cbc) side to compare — that is a limit of the record, not a statement that Cannabichromene (cbc) has no side effects.

How much people look this up

Where Cannabichromene (cbc) and Ranibizumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabichromene (cbc)

Top half

#645 of 1,452 supplements looked up here in the last 7 days

29 days ago today

Medication Ranibizumab

Steady interest

#2,286 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?

Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Cannabichromene (cbc) reference on this page ↓
Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Cannabichromene (cbc) and Ranibizumab records this page draws on were last updated June 20, 2026.
What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.

Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD, BCPS.

Supplement

About Cannabichromene (cbc)

What is Cannabichromene (cbc)?

Pain relief
Inflammation
Mood and anxiety
Skin and acne concerns
Brain and nerve health

Cannabichromene (CBC) is a non-intoxicating cannabinoid found in the cannabis plant that is being studied for possible pain, anti-inflammatory, and nervous-system effects. Almost all current evidence comes from laboratory and animal research, so we do not yet know how well it works or how safe it is in people. Talk with your pharmacist or doctor before using any CBC product, and avoid it during pregnancy and breastfeeding.

Cannabaceae · Flowers and resin of the cannabis plant (where the cannabinoid is concentrated) · Oils and tinctures, capsules, edibles, full-spectrum hemp extracts, vape products

An interaction check asks whether these two react with each other — it does not ask whether Cannabichromene (cbc) is a good idea for someone in your situation. Here is what our Cannabichromene (cbc) record says about it on its own.

Cannabichromene (cbc): dosing

There is no established or standardized dose for CBC. Because human research is so limited, experts cannot recommend a specific amount that is known to be safe or effective.If you choose to try a CBC product, follow the directions on the product label and consider starting low. Look for products that have been tested by an independent lab and provide a certificate of analysis.

From our Cannabichromene (cbc) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Cannabichromene (cbc) monograph & all interactions

Medication

About Ranibizumab Injection

What Is Ranibizumab Injection Used For?

Brand names: Lucentis, Susvimo

Ranibizumab injection treats serious eye conditions that involve abnormal blood vessel growth or fluid leakage in the eye. It is used for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR).

Susvimo (ranibizumab injection) is specifically approved for patients with wet AMD, DME, or DR who have already responded to at least two intravitreal (into-the-eye) injections of a VEGF inhibitor medication. Lucentis (ranibizumab injection) is used for wet AMD, DME, diabetic retinopathy, macular edema following retinal vein occlusion, and myopic choroidal neovascularization (abnormal blood vessel growth related to severe nearsightedness).

Most-Reported Side Effects for Ranibizumab

From FAERS, the FDA’s public side-effect reporting system (26,591 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Visual acuity reduced 2,907 reports

Visual impairment 1,654 reports

Cerebrovascular accident 1,238 reports

Blindness 1,051 reports

Eye haemorrhage 1,047 reports

See full Ranibizumab Injection drug information

Keep checking

Other Drugs & Cannabichromene (cbc)

Browse every other medication we’ve checked against Cannabichromene (cbc) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major

248Moderate

0Minor

2,581No known interaction

248 Moderate 2,581 No interaction

Moderate

248 interactions

Showing 60 of 248 moderate interactions — see all 248 on the Cannabichromene (cbc) page.

No interaction 2,581 drugs checked — show the list

We also checked Cannabichromene (cbc) against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,581 medications checked with no known interaction — see the full Cannabichromene (cbc) list.

See the full Cannabichromene (cbc) interactions page

See every supplement checked against Ranibizumab, ranked by severity

Evidence & sources

Cannabichromene (cbc) References

The 1 references that drive our Cannabichromene (cbc) monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Hatoum NS, Davis WM, Waters IW, Elsohly MA, Turner CE. Synergism of cannabichromene and CNS depressants in mice. Gen Pharmacol. 1981;12(5):351-6. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Cannabichromene (cbc) and Ranibizumab Together: Common Questions

Is it safe to take Cannabichromene (cbc) with Ranibizumab?

We do not list a known interaction between Cannabichromene (cbc) and Ranibizumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.

Does Cannabichromene (cbc) interact with any other medications?

Yes. Cannabichromene (cbc) has 248 documented drug interactions in our database — Ranibizumab is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

Cannabichromene (cbc) monograph Uses, safety profile, and every drug interaction in one place Ranibizumab Injection drug information The full plain-English guide to this medication Ranibizumab supplement interactions Every supplement checked against Ranibizumab, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 1 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Ranibizumab and Cannabichromene (cbc)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.